EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Treg Cells Modulate Neuroinflammation and Behavioral Deficits in Autism: Evidence From MR ‐Based Genetic Analyses and Experimental Models

Zuqing Nie iD, Xinyi Xu iD, Junhao Chen, Huiling Chen, Meng Li, Yang Zhang, Zhiwei Li, Chen Shen, Jie Wen, Xia Cao iD

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2026

DOI: 10.1002/ajmg.b.33061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2026. Verfasst von Zuqing Nie und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Central Lab, the Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Autism Spectrum Disorder, Neuroinflammatory Diseases, Autistic Disorder. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Yunnan Province Biomedical Special Project, the Yunnan Province Li Bin Expert Work Station Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autism spectrum disorder (ASD) is a neurodevelopmental condition that is increasingly linked to immune dysfunction and neuroinflammation. Regulatory T cells (Tregs), which are crucial in maintaining immune homeostasis, have been implicated in the pathogenesis of ASD. However, their role in neuroimmune interactions and behavioral outcomes remains poorly understood. We employed Mendelian Randomization (MR) to assess the causal relationship between Tregs and ASD risk, using genetic data to infer causality. To further confirm the reliability of the MR results, we incorporated data from an independent genome‐wide association study (GWAS) and conducted a meta‐analysis to strengthen causal inference. Additionally, we validated our findings in an ASD‐like mouse model (BTBR mice) treated with the IL‐2/JES6.1 complex to enhance Tregs' function. Neuroinflammation and behavioral outcomes were assessed in treated and control mice. MR analysis revealed significant associations between several Tregs subsets and ASD risk. The proportion of CD127 ‒ CD8 + T cells among total T cells showed a consistent protective effect (OR = 0.84, p = 0.01166), which was validated across multiple analytical methods. The absolute count of resting CD4 + regulatory T cells was also inversely associated with ASD risk and demonstrated an independent protective effect in multivariable MR analysis. Sensitivity analyses revealed no evidence of horizontal pleiotropy or heterogeneity. Experimental treatment with IL‐2/JES6.1 in BTBR mice significantly increased CD4 + Tregs populations, enhanced CD4 + Tregs activation, and improved social interactions and repetitive behavior. Furthermore, IL‐2/JES6.1 treatment reduced neuroinflammatory markers, including microglial activation. Transcriptomic analysis revealed that IL‐2/JES6.1 treatment induced neuroendocrine and synaptic plasticity pathways in the hippocampus and cortex while suppressing inflammatory signaling. This study demonstrates that Tregs modulation can influence ASD pathogenesis through immune regulation and behavioral improvement. Our findings highlight the potential of Treg‐targeted therapies for ASD. Future studies should focus on the mechanistic pathways involved and explore the clinical applicability of these therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

T-Lymphocytes, RegulatoryAutism Spectrum DisorderNeuroinflammatory DiseasesAutistic DisorderAnimalsMiceDisease Models, AnimalHumansGenome-Wide Association StudyMendelian Randomization AnalysisInflammationMaleGenetic Predisposition to Disease

Stichwörter der Autor:innen

BTBR miceIL‐2 therapyautism spectrum disorderimmune dysregulationmendelian randomizationneuroinflammationregulatory T cells

Autor:innen und Institutionen

  • The Central Lab, the Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
  • Department of Urology, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
  • Department of Vascular Surgery, Fuwai Yunnan Cardiovascular Hospital, Affiliated Cardiovascular Hospital of Kunming Medical University, Kunming, People's Republic of China.
  • Department of Science and Education, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, P. R. China.

ORCID-Profile: Zuqing Nie, Xinyi Xu, Xia Cao

Förderung

  • National Natural Science Foundation of China
  • Yunnan Province Biomedical Special Project
  • the Yunnan Province Li Bin Expert Work Station Foundation
  • the Joint Special Project of Yunnan Provincial Department of Science and Technology and Kunming Medical University
  • The Second Affiliated Hospital of Kunming Medical University Talent Program

Zitieren

APA

Nie, Z., Xu, X., Chen, J., Chen, H., Li, M., Zhang, Y., Li, Z., Shen, C., Wen, J., & Cao, X. (2026). Treg Cells Modulate Neuroinflammation and Behavioral Deficits in Autism: Evidence From MR ‐Based Genetic Analyses and Experimental Models. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.33061

Vancouver

Nie Z, Xu X, Chen J, Chen H, Li M, Zhang Y, et al. Treg Cells Modulate Neuroinflammation and Behavioral Deficits in Autism: Evidence From MR ‐Based Genetic Analyses and Experimental Models. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2026. doi:10.1002/ajmg.b.33061

BibTeX
@article{Nie2026,
  author = {Nie, Zuqing and Xu, Xinyi and Chen, Junhao and Chen, Huiling and Li, Meng and Zhang, Yang and Li, Zhiwei and Shen, Chen and Wen, Jie and Cao, Xia},
  title = {Treg Cells Modulate Neuroinflammation and Behavioral Deficits in Autism: Evidence From MR ‐Based Genetic Analyses and Experimental Models},
  journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
  year = {2026},
  doi = {10.1002/ajmg.b.33061}
}
Kostenlos starten →